Login
Toggle navigation
Videos
Categories
Trending
Richard Hooper interviews David Grocott about HUBER+SUHNER's recent acquisition of Phoenix Dynamics Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Roger Moss and Chen Lin discuss Labrador Gold Corp.'s focus on gold exploration in Eastern Canada, emphasizing the Kingsway project's promising results and substantial funding for further drilling.|Roger Moss, President & Director of Labrador Gold Corp.
00:10:00
Revolutionizing Breast Cancer Treatment: Innovative Drug Trials and Collaborations Target Aggressive Forms of the Disease |Dr. Quay , CEO, Atossa Therapeutics Inc.
00:10:00
Early-stage venture capital firm investing at the two forces|Noramay Cadena,Managing Partner,Supply Change Capital
00:10:00
Graphite's Role in the Battery Value Chain: From Mining to Advanced Applications
00:10:00
Avrupa Minerals: Advancing Early-Stage Copper, Lead, and Zinc Projects in Europe with Strategic Partnerships
00:10:00
Q2 2024 Market Insights: Hilltop Wealth Advisors on Inflation, AI, and Fed Strategies - Rusty and Brittany | Hilltop Wealth Advisors
00:10:00
Optimizing Accuracy in Medical Transcription Through Dual AI Model Integration| Manny Krakaris , CEO, Augmedix Inc.
00:10:00
Forum Energy's Aberdine Project: Unveiling a High-Grade Uranium District
00:10:00
Robert Ogór on AMBRA SA's Wine Market Strategy and Increased Dividend Expectations | Robert Ogór, President, AMBRA SA.
00:10:00
Wesdome COO Discusses Kiena Mine Growth | FRED MERCIER-LANGEVIN - COO of Wesdome Gold Mines
00:10:00
Marco Claudio Grillo on Resilience and Growth at Euronext STAR Conference 2022 | Marco Claudio Grillo, CEO , Abitare In SpA.
00:10:00
Geri focuses on B2B software companies that are revolutionizing legacy workflows|Geri Kirilova,Partner, Laconia